GSK's Arexvy Vaccine Demonstrates Strong Efficacy Against RSV in Older Adults

Retrieved on: 2024-10-09 14:46:17

Tags for this article:

Subunit vaccines

Respiratory syncytial virus vaccine

Vaccines

Respiratory syncytial virus

RSV

Palivizumab

Click the tags to see associated articles and topics

GSK's Arexvy Vaccine Demonstrates Strong Efficacy Against RSV in Older Adults. View article details on hiswai:

Excerpt

Evaluating Safety and Efficacy of Vaxart's Oral Vaccine's Impact on COVID-19 Variants ... mRNA Capping: A Component That Protects the COVID-19 Vaccine ...

Article found on: www.contagionlive.com

View Original Article